banner add

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

from NYT > Health https://ift.tt/pTq5nkA
via IFTTT

No comments

A Loophole Brings Cystic Fibrosis Patients a ‘Miracle Drug’ in Generic Form

A generic version of a breakthrough cystic fibrosis drug, manufactured in Bangladesh for a fraction of the American price, may give some fam...

Theme images by PLAINVIEW. Powered by Blogger.